☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
HLX04
Henlius Presents P-III Data of HLX04 (biosimilar- bevacizumab) at CSCO 2020
September 20, 2020
Henlius Reports NMPA's Acceptance of NDA for HLX04 (biosimilar- bevacizumab)
September 11, 2020
Load more...
Back to Home
